详情请点击：叶黄素就选今馨尔

Avedro is a privately held pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.

Our mission is to produce and deliver innovative, minimally invasive, drugs and devices for corneal remodeling to eye care professionals around the world to improve patients’ vision and quality of life. Avedro’s talented and motivated employees deliver premium, differentiated, high quality products and experiences in order to delight our customers, establish and maintain ourselves as the market leader and increase our enterprise value.

Avedro’s products sold outside of the United States include capital equipment such as the UV-X devices, the KXL and Mosaic™ Systems, and related proprietary pharmaceuticals such as the VibeX® and MedioCROSS® formulations. Avedro distributes its products in countries outside of the United States through a network of ophthalmic medical device distributors.
 

部分翻译仅供参考：

Avedro是一家私营的医药和医疗器械公司，致力于推动角膜交联和屈光矫正的科学和技术。
我们的使命是为世界各地的眼科护理专家生产和提供创新的、微创的、用于角膜重塑的药物和设备，以改善患者的视力和生活质量。Avedro富有才华、积极进取的员工为客户提供优质、差异化、高品质的产品和体验，以满足客户的需求，树立并保持市场领先地位，提升企业价值。

      

公司网址 http://avedro.com/

相关报道：中国药监局核准Avedro的KXL系统

（更新时间：2023-8-7 SONG CHENG cheng）